Published in J Clin Epidemiol on October 01, 1995
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J (2008) 2.64
Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care (2009) 1.87
Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart (2007) 1.14
Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med (2004) 1.10
Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study. Clin Res Cardiol (2011) 0.88
Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Exp Biol Med (Maywood) (2015) 0.79
Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand? Cardiovasc Ther (2013) 0.77
Resting heart rate in first year survivors of myocardial infarction and long-term mortality: a community study. Mayo Clin Proc (2014) 0.76
Measuring the acute cardiovascular effects of shisha smoking: a cross-sectional study. JRSM Open (2014) 0.76
Increased heart rate on first day in Intensive Care Unit is associated with increased mortality. Pak J Med Sci (2017) 0.75
Resting heart rate in patients with ischemic heart disease in Saudi Arabia and Egypt. J Saudi Heart Assoc (2011) 0.75
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
An introduction to the Barell body region by nature of injury diagnosis matrix. Inj Prev (2002) 4.27
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA (1998) 3.37
Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol (1995) 2.98
Unresolved problems in coronary care. Am J Cardiol (1967) 2.59
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med (1993) 2.43
In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation (1991) 2.13
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study Group. Eur Heart J (1997) 2.08
Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation (2000) 2.02
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01
Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol (1999) 2.00
Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. Arch Fam Med (1995) 1.96
Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology (1994) 1.91
Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males inIsrael. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol (1977) 1.78
High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol (1979) 1.75
Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology (2004) 1.70
Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol (1998) 1.67
Reversible dissociation of the poliovirus replication complex: functions and interactions of its components in viral RNA synthesis. J Virol (1996) 1.65
Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes. Eur Heart J (1999) 1.63
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol (1997) 1.62
Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med (1975) 1.62
Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol (1999) 1.60
Q-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoning. Am J Cardiol (1982) 1.59
Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med (1976) 1.58
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol (1990) 1.58
Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol (1998) 1.56
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52
The rationale of magnesium supplementation in acute myocardial infarction. A review of the literature. Arch Intern Med (1992) 1.47
Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation (1998) 1.47
Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) (1985) 1.44
Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Eur Heart J (2000) 1.43
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol (1999) 1.42
Q wave and Non-Q wave myocardial infarction after thrombolysis. J Am Coll Cardiol (1995) 1.41
Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1996) 1.41
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41
Assessment of a creatine kinase-MB/myoglobin kit in the prehospital setting in patients presenting with acute nontraumatic chest pain: the "Shahal" experience. Crit Care Med (1999) 1.40
Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol (1996) 1.40
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40
Pronus angina (angina pectoris induced by stooping or crouching). A proposed mechanism. Chest (1993) 1.40
Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation (1979) 1.36
A new approach to the analysis of multiple injuries using data from a national trauma registry. Inj Prev (2003) 1.33
The early recognition of right ventricular infarction: diagnostic accuracy of the electrocardiographic V4R lead. Circulation (1983) 1.30
Diabetes, prediabetes and uricaemia. Diabetologia (1976) 1.29
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study. J Chronic Dis (1971) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Uric acid and diabetes: observations in a population study. Lancet (1982) 1.24
Wenckebach A-V block: a frequent feature following heavy physical training. Am Heart J (1975) 1.24
Unsuspected cerebral perfusion. A complication of the use of a central venous pressure catheter. Chest (1978) 1.22
Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. J Chronic Dis (1973) 1.22
Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med (1971) 1.22
Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol (1990) 1.21
Gingival hyperplasia caused by nifedipine--a preliminary report. Int J Cardiol (1984) 1.20
Nucleotide sequence and organization of eight 3' open reading frames of the citrus tristeza closterovirus genome. Virology (1994) 1.18
Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol (2000) 1.18
Genetic aspects of arteriosclerosis. Arteriosclerosis (1986) 1.16
Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. Chest (1983) 1.15
Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med (1976) 1.13